Hemispherx Biopharma Signs the Latest in a Series of R&D Deals for Flu Therapeutics in 2005
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 67 (Table of Contents)
Published: 6 Jan-2006
DOI: 10.3833/pdr.v2006.i67.570 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Hemispherx Biopharma entered into agreement with Defence R&D Canada to evaluate its influenza therapeutic Ampligen® in animal models of human flu...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS